NEW YORk, May 18 (GenomeWeb News) - Bruker Biosciences CEO Frank Laukien bought more than $1.1 million worth of his company's shares since May 10, sending the stock up 12.7 percent to $3.99 in mid-afternoon trading today.
According to Insidercow.com, which tracks insider trading at public companies, Laukien bought 277,430 shares of Bruker stock at prices between $3.60 and $3.00 per share between May 10 and May 17.